Disc Medicine, Inc.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Large accelerated filer
Business Address 321 ARSENAL STREET, SUITE 101, WATERTOWN, MA, 02472
Mailing Address 321 ARSENAL STREET, SUITE 101, WATERTOWN, MA, 02472
Phone (617) 674-9274
Fiscal Year End 1231
EIN 851612845
Financial Overview
FY2024
-$76.43M
Net Income
$53.19M
Total Liabilities
$360.38M
Cash & Equivalents
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | February 13, 2026 | View on SEC |
| 4 Insider stock transaction report | February 11, 2026 | View on SEC |
| 4 Insider stock transaction report | February 11, 2026 | View on SEC |
| 4 Insider stock transaction report | February 11, 2026 | View on SEC |
| 4 Insider stock transaction report | February 11, 2026 | View on SEC |
| 4 Insider stock transaction report | February 11, 2026 | View on SEC |
| 4 Insider stock transaction report | February 11, 2026 | View on SEC |
| 4 Insider stock transaction report | January 21, 2026 | View on SEC |
| 8-K Current report of material events | January 12, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | January 7, 2026 | View on SEC |
Material Events
8-K Other February 13, 2026
High Impact
- Disc Medicine received a Complete Response Letter (CRL) from the FDA for its lead drug candidate, bitopertin.
- The CRL prevents approval of bitopertin for Erythropoietic Protoporphyria (EPP) in its current form, requiring more information or addressing unresolved concerns.
Insider Trading
STRONG SELL 4 insiders
33 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Werewolf Therapeutics, Inc.
HOWL Pharmaceutical Preparations
Zenas BioPharma, Inc.
ZBIO Pharmaceutical Preparations
Centessa Pharmaceuticals plc
CNTA Pharmaceutical Preparations
Karyopharm Therapeutics Inc.
KPTI Pharmaceutical Preparations
VERTEX PHARMACEUTICALS INC / MA
VRTX Pharmaceutical Preparations
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.